Cargando…

Saxagliptin Attenuates Albuminuria by Inhibiting Podocyte Epithelial- to-Mesenchymal Transition via SDF-1α in Diabetic Nephropathy

The dipeptidyl peptidase-4 (DPP-4) inhibitor saxagliptin has been found to reduce progressive albuminuria, but the exact mechanism of inhibition is unclear. Podocyte epithelial-to-mesenchymal transition (EMT) has emerged as a potential pathway leading to proteinuria in diabetic nephropathy (DN). Str...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Yun-peng, Sun, Bei, Han, Zhe, Han, Fei, Hu, Shao-lan, Li, Xiao-yu, Xue, Mei, Yang, Yang, Chen, Li, Li, Chun-jun, Chen, Li-ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5672017/ https://www.ncbi.nlm.nih.gov/pubmed/29163166 http://dx.doi.org/10.3389/fphar.2017.00780

Ejemplares similares

Quercetin Attenuates Podocyte Apoptosis of Diabetic Nephropathy Through Targeting EGFR Signaling
por: Liu, Yiqi, et al.
Publicado: (2022)

Fisetin Attenuates Diabetic Nephropathy-Induced Podocyte Injury by Inhibiting NLRP3 Inflammasome
por: Dong, Wenmin, et al.
Publicado: (2022)

Triptolide markedly attenuates albuminuria and podocyte injury in an animal model of diabetic nephropathy
por: MA, RUIXIA, et al.
Publicado: (2013)

Modified Huangqi Chifeng Decoction Attenuates Proteinuria by Reducing Podocyte Injury in a Rat Model of Immunoglobulin a Nephropathy
por: Chang, Meiying, et al.
Publicado: (2021)

Gold nanoparticles attenuate albuminuria by inhibiting podocyte injury in a rat model of diabetic nephropathy
por: Alomari, Ghada, et al.
Publicado: (2019)

Epigenetic Alterations in Podocytes in Diabetic Nephropathy
por: Sugita, Erina, et al.
Publicado: (2021)

Src Activation Aggravates Podocyte Injury in Diabetic Nephropathy via Suppression of FUNDC1-Mediated Mitophagy
por: Zheng, Ting, et al.
Publicado: (2022)

Tiaolipiwei Acupuncture Reduces Albuminuria by Alleviating Podocyte Lesions in a Rat Model of Diabetic Nephropathy
por: Zhang, Zhilong, et al.
Publicado: (2018)

Catalpol Ameliorates Podocyte Injury by Stabilizing Cytoskeleton and Enhancing Autophagy in Diabetic Nephropathy
por: Chen, Yan, et al.
Publicado: (2019)

ROCK1 Induces Endothelial-to-Mesenchymal Transition in Glomeruli to Aggravate Albuminuria in Diabetic Nephropathy
por: Peng, Hui, et al.
Publicado: (2016)

Microtubule associated protein 4 phosphorylation-induced epithelial-to-mesenchymal transition of podocyte leads to proteinuria in diabetic nephropathy
por: Li, Lingfei, et al.
Publicado: (2022)

Huidouba Improved Podocyte Injury by Down-Regulating Nox4 Expression in Rats With Diabetic Nephropathy
por: Yang, KunBao, et al.
Publicado: (2020)

Tangeretin attenuates bleomycin-induced pulmonary fibrosis by inhibiting epithelial-mesenchymal transition via the PI3K/Akt pathway
por: Li, Jiang, et al.
Publicado: (2023)

Myricetin suppresses TGF-β-induced epithelial-to-mesenchymal transition in ovarian cancer
por: Yang, Hui-Wen, et al.
Publicado: (2023)

Zuogui Wan ameliorates high glucose-induced podocyte apoptosis and improves diabetic nephropathy in db/db mice
por: Zhu, Bingbing, et al.
Publicado: (2022)

Podocytes are likely the therapeutic target of IgA nephropathy with isolated hematuria: Evidence from repeat renal biopsy
por: Luo, Mian-Na, et al.
Publicado: (2023)

Puerarin Attenuates Diabetic Nephropathy by Promoting Autophagy in Podocytes
por: Li, Xueling, et al.
Publicado: (2020)

SGLT2 inhibitors suppress epithelial–mesenchymal transition in podocytes under diabetic conditions via downregulating the IGF1R/PI3K pathway
por: Guo, Ruixue, et al.
Publicado: (2022)

Implication of CD38 gene in podocyte epithelial-to-mesenchymal transition and glomerular sclerosis
por: Boini, Krishna M, et al.
Publicado: (2012)

Inhibition of Renal Tubular Epithelial Mesenchymal Transition and Endoplasmic Reticulum Stress-Induced Apoptosis with Shenkang Injection Attenuates Diabetic Tubulopathy
por: Wang, Wen-Wen, et al.
Publicado: (2021)

Elabela Attenuates the TGF-β1-Induced Epithelial-Mesenchymal Transition of Peritoneal Mesothelial Cells in Patients Receiving Peritoneal Dialysis
por: Xie, Shunyun, et al.
Publicado: (2022)

Corrigendum: SGLT2 inhibitors suppress epithelial-mesenchymal transition in podocytes under diabetic conditions via downregulating the IGF1R/PI3K pathway
por: Guo, Ruixue, et al.
Publicado: (2022)

Dl-3-n-Butylphthalide Ameliorates Diabetic Nephropathy by Ameliorating Excessive Fibrosis and Podocyte Apoptosis
por: Xu, Jingyu, et al.
Publicado: (2021)

A Novel Epithelial-Mesenchymal Transition Gene Signature Correlated With Prognosis, and Immune Infiltration in Hepatocellular Carcinoma
por: Kong, Weihao, et al.
Publicado: (2022)

Long noncoding RNA ENSRNOG00000037522 is involved in the podocyte epithelial-mesenchymal transition in diabetic rats
por: Ling, Li, et al.
Publicado: (2018)

High glucose induces podocyte epithelial-to-mesenchymal transition by demethylation-mediated enhancement of MMP9 expression
por: Ling, Li, et al.
Publicado: (2018)

Aristolochic Acid Causes Albuminuria by Promoting Mitochondrial DNA Damage and Dysfunction in Podocyte
por: Zhou, Yang, et al.
Publicado: (2013)

CD82 attenuates TGF-β1-mediated epithelial-mesenchymal transition by blocking smad-dependent signaling in ARPE-19 cells
por: Lee, Hyesook, et al.
Publicado: (2022)

Molecular mechanisms of COVID-19-induced pulmonary fibrosis and epithelial-mesenchymal transition
por: Pi, Peng, et al.
Publicado: (2023)

Morphine Induces Albuminuria by Compromising Podocyte Integrity
por: Lan, Xiqian, et al.
Publicado: (2013)

Tanshinone IIA Inhibits Epithelial-to-Mesenchymal Transition Through Hindering β-Arrestin1 Mediated β-Catenin Signaling Pathway in Colorectal Cancer
por: Song, Qing, et al.
Publicado: (2020)

Chronic unpredicted mild stress-induced depression alter saxagliptin pharmacokinetics and CYP450 activity in GK rats
por: Xia, Zhengchao, et al.
Publicado: (2016)

Huangqin Tang Interference With Colitis Associated Colorectal Cancer Through Regulation of Epithelial Mesenchymal Transition and Cell Cycle
por: Ma, Xuran, et al.
Publicado: (2022)

Astragaloside IV Attenuates Podocyte Apoptosis Mediated by Endoplasmic Reticulum Stress through Upregulating Sarco/Endoplasmic Reticulum Ca(2+)-ATPase 2 Expression in Diabetic Nephropathy
por: Guo, Hengjiang, et al.
Publicado: (2016)

Corrigendum: Tanshinone IIA Inhibits Epithelial-to-Mesenchymal Transition Through Hindering β-Arrestin1 Mediated β-Catenin Signaling Pathway in Colorectal Cancer
por: Song, Qing, et al.
Publicado: (2022)

Natural Plants Compounds as Modulators of Epithelial-to-Mesenchymal Transition
por: Avila-Carrasco, Lorena, et al.
Publicado: (2019)

Tackle Epithelial-Mesenchymal Transition With Epigenetic Drugs in Cancer
por: Dong, Bo, et al.
Publicado: (2020)

Epithelial-to-Mesenchymal Transition in Fibrosis: Concepts and Targeting Strategies
por: Lovisa, Sara
Publicado: (2021)

microRNA Crosstalk Influences Epithelial-to-Mesenchymal, Endothelial-to-Mesenchymal, and Macrophage-to-Mesenchymal Transitions in the Kidney
por: Srivastava, Swayam Prakash, et al.
Publicado: (2019)

Network Pharmacology and Experimental Verification Strategies to Illustrate the Mechanism of Jian-Pi-Yi-Shen Formula in Suppressing Epithelial–Mesenchymal Transition
por: Zhao, Yuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s96ec98730odrdcu147nli4h3d